Candel Therapeutics, Inc. (CADL) Operating Margin % [USD] 2021 - 2022

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Candel Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2022.
  • Candel Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2022 was -27.8 K %, a 35% decline year-over-year.
  • Candel Therapeutics, Inc. annual Operating Margin for 2022 was -27.8 K %, a 35% decline from 2021.
  • Candel Therapeutics, Inc. annual Operating Margin for 2021 was -20.6 K %, a 86.3% decline from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -27.8 K -7.2 K -35% Oct 1, 2022 Dec 31, 2022
Q3 2022 -27.5 K Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.8 K Apr 1, 2022 Jun 30, 2022
Q1 2022 -24 K Jan 1, 2022 Mar 31, 2022
Q4 2021 -20.6 K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.